Of the 564 patients surveyed, 93% expected to receive an antibiotic for one of the five pre-defined illnesses/symptoms, with ...

Included in the study were 1,664 children (442 born before the pandemic and 1,222 born during the pandemic), of whom 997 were ...

Swiss drugmaker Basilea Pharmaceutica is receiving $29 million in BARDA funding to develop two first-in-class antifungals to ...

The pledge came with at least $500 million in outbreak support, along with a plan to help bolster the domestic mpox vaccine ...

For all children in the study, advanced maternal age, gestational high blood pressure, cesarean delivery, and being a boy ...

More than half of surveyed pharmacists said they do not consistently adhere to guidelines when dispensing antibiotics.

One of the most striking findings was that post-COVID deficits in hospitalized patients look similar to 20 years of normal ...

On September 26, the eyes of antimicrobial resistance (AMR) experts everywhere will be on New York, where world leaders and ...

The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) today confirmed 18 more H5N1 avian ...

Jynneos, developed in 2019 by Bavarian Nordic, is supposed to be administered as two doses given 28 days apart. A live ...

A new study of outcomes among more than 33,000 hospitalized COVID-19 patients shows that remdesivir plus dexamethasone ...

In other H5N1 developments, the FDA's vaccine advisory group said it will discuss the composition of H5 vaccines when it ...